Clinical Trial Update: A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase 1 trial comparing Trifarotene Cream 0.005% with AKLIEF Cream (US reference listed drug) and the Canadian reference…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AKLIEF Cream (trifarotene)
• Trifarotene Cream 0.005% (trifarotene)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED